Surveillance for cardiotoxicity in patients receiving potentially cardiotoxic chemotherapy

As cancer survival has improved, some of the focus of care has shifted to minimizing the long-term complications of cancer therapy. Cardiovascular disease is a leading long-term cause of morbidity and mortality in patients who survive cancer. This chapter focuses on current clinical imaging and non-imaging techniques that are used to detect the cardiovascular consequences of chemotherapy. Overall, the detection and quantification of chemotherapy-induced myocardial injury, dysfunction, and heart failure is challenging due to intrinsic limitations of the available imaging techniques coupled with the latency period that can occur between injury and clinical presentation with heart failure.